RSS

agreement

Biopharmaceutical company, Secarna Pharmaceuticals, has entered into a co-development agreement with research and development company, Firebrand Therapeutics, for novel cancer therapies. more

News

Catalent Pharma Solutions, global provider of advanced delivery technologies and development solutions, has signed a commercial manufacturing agreement with Aucta Pharmaceuticals to formulate vigabatrin into a novel dosage form. more

News

A new agreement in the peptide therapeutics area between integrated drug discovery company, IRBM, and Merck (which is known as MSD outside the US and Canada) has been announced. more

News

Global specialty pharma company, Theramex, and private pharma company, Endoceutics, have entered into a definitive agreement for the exclusive licensing of Intrarosa (Prasterone) in Europe, Australia, Russia and the Ukraine. more

News

A licensing and supply agreement has been signed by Gyros Protein Technologies and Cygnus Technologies for the development of immunoassay kits for biotherapeutic impurity analysis. more

News

Catalent, global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has signed an agreement for the acquisition of Juniper Pharmaceuticals. more

News

Abcam (supplier of life science research tools) has signed a memorandum of understanding with Shuwen Biotech (company focused on the development & commercialisation of companion diagnostics — CDx) to establish global alliance for CDx kit development more

News

Mologic (developer of personalised diagnostics) has signed agreements with two medical companies — Medisur and Peripal — for the distribution of a rapid point-of-care (POC) test for the detection of infection in patients on peritoneal dialysis (PD) more

Technology

International nonprofit organization, PATH, and UK-based test developer, Mologic, have entered into an agreement to advance a new rapid diagnostic test to support treatment and elimination of Plasmodium vivax or relapsing malaria. more

Technology

Healthcare solutions provider, Novartis, has entered into an agreement with GlaxoSmithKline to divest its 36.5% stake in its consumer healthcare joint venture for $13 billion. more

News

Lundbeck has signed a definitive agreement to acquire biopharma company, Prexton Therapeutics, obtaining the global rights for foliglurax — a treatment for Parkinson’s that has recently entered clinical Phase II testing. more

News

Roche has revealed it will acquire healthcare technology and services company, Flatiron Health, in an agreement that will see the companies leverage their respective expertise to advance industry-wide development and delivery of oncology medicines. more

News

Horizon Discovery Group, gene editing and modulation technologies company, has entered into a non-exclusive out-licensing agreement with a US-based immune-oncology therapeutics developer. more

News

Global healthcare information and communication technology (ICT) provider, Ascom, has been selected by Munson Healthcare to provide a comprehensive technology retrofit of its flagship medical centre. more

Technology

Addex Therapeutics has signed a licensing and collaboration agreement with Indivior to accelerate the global development and commercialisation of its addiction treatment, ADX71441. more

News

Recipharm has taken a step further in its development and growth in the Indian market by acquiring the remaining shares in Nitin Lifesciences. more

News

UK-based synthetic biology company, Oxford Genetics, has established a new agreement with clinical-stage gene therapy company, MeiraGTx, for the development of novel adeno-associated virus (AAV) vectors. more

News

Molecular diagnostics company, Biocartis, has signed a companion diagnostic (CDx) development agreement with biotechnology company, Amgen, for the Idylla RAS biomarker tests. more

News

Sanofi and Principia Biopharma have entered into an agreement to develop a clinical-stage oral drug candidate as a potential therapy for multiple sclerosis (MS) and other central nervous system (CNS) diseases. more

News

Developer of next-generation transdermal drug delivery patches, Medherant, has signed an agreement with a Japanese transdermal patch company to evaluate the potential of the TEPI Patch technology. more

Technology